Towards an inventory of oncogenic mutations in cancer;Vers un inventaire des mutations oncogéniques dans les cancers humains

Bulletin du Cancer

Volumn 97, Issue 11, 2010, Pages 1223-1229

  Theillet, C ^a  

^a INSERM   (France)

Author keywords

Genome; Mutation; Oncogene; Oncogenic cascades; Tumor suppressor

Indexed keywords

MICRORNA;

CANCER GENETICS; CARCINOGENESIS; EPIGENETICS; GENE MUTATION; GENE REARRANGEMENT; HUMAN; MALIGNANT NEOPLASTIC DISEASE; ONCOGENE; REVIEW; SOMATIC MUTATION; TUMOR GENE; TUMOR SUPPRESSOR GENE; DISEASE COURSE; GENETICS; GENOMIC INSTABILITY; HUMAN GENOME; MOLECULAR GENETICS; MUTATION; NEOPLASM; PHYSIOLOGY;

DISEASE PROGRESSION; GENE REARRANGEMENT; GENES, TUMOR SUPPRESSOR; GENOME, HUMAN; GENOMIC INSTABILITY; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASMS; ONCOGENES;

EID: 78650151378     PISSN: 00074551     EISSN: 17696917     Source Type: Journal    
DOI: 10.1684/bdc.2010.1200     Document Type: Review

References (15)

1. Stehelin D, Varmus HE, Bishop JM, Vogt PK. DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA. Nature 1976 ; 260 : 170-3.
2. Shimizu K, Goldfarb M, Suard Y, Perucho M, Li Y, Kamata T, et al. Three human transforming genes are related to the viral ras oncogenes. Proc Natl Acad Sci USA 1983 ; 80 : 2112-6. (Pubitemid 13097145)
3. Land H, Chen AC, Morgenstern JP, Parada LF, Weinberg RA. Behavior of myc and ras oncogenes in transformation of rat embryo fibroblasts. Mol Cell Biol 1986 ; 6 : 1917-25.
4. Hansen MF, Cavenee WK. Tumor suppressors: recessive mutations that lead to cancer. Cell 1988 ; 53 : 173-4.
5. Trent JM, Stanbridge EJ, McBride HL, Meese EU, Casey G, Araujo DE, et al. Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science 1990 ; 247 : 568-71.
6. Goodrich DW, Lee WH. The molecular genetics of retinoblastoma. Cancer Surv 1990 ; 9 : 529-54.
7. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990 ; 61 : 759-67.
8. Nowell PC. Mechanisms of tumor progression. Cancer Res 1986 ; 46 : 2203-7.
9. Zimonjic D, Brooks MW, Popescu N, Weinberg RA, Hahn WC. Derivation of human tumor cells in vitro without widespread genomic instability. Cancer Res 2001 ; 61 : 8838-44. (Pubitemid 34013898)
10. Orsetti B, Courjal F, Cuny M, Rodriguez C, Theillet C. 17q21-q25 aberrations in breast cancer: combined allelotyping and CGH analysis reveals 5 regions of allelic imbalance among which two correspond to DNA amplification. Oncogene 1999 ; 18 : 6262-70.
11. Theillet C, Orsetti B, Redon R, Manoir SD. Genomic profiling: from molecular cytogenetics to DNA arrays. Bull Cancer 2001 ; 88 : 261-8. (Pubitemid 32324466)
12. Liyanage M, Coleman A, du Manoir S, Veldman T, McCormack S, Dickson RB, et al. Multicolour spectral karyotyping of mouse chromosomes. Nat Genet 1996 ; 14 : 312-5.
13. Jacquemier J, Ginestier C, Charafe-Jauffret E, Bertucci F, Bege T, Geneix J, et al. Small but high throughput: how "tissue-microarrays" became a favorite tool for pathologists and scientists. Ann Pathol 2003 ; 23 : 623-32.
14. Bignell GR, Greenman CD, Davies H, Butler AP, Edkins S, Andrews JM, et al. Signatures of mutation and selection in the cancer genome. Nature 2010 ; 463 : 893-8.
15. Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature 2010 ; 464 : 999-1005.